Your session is about to expire
← Back to Search
Behavioral Intervention
Reciprocal Imitation Training for Autism
N/A
Recruiting
Led By Wendy L Stone, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
The child has a diagnosis of ASD or displays social communication impairments
Be younger than 18 years old
Must not have
The parent or child has previously received RIT or coaching in another NDBI
The child has visual, hearing, or motor conditions that would compromise his/her ability to participate in RIT or assessments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 9 months
Awards & highlights
No Placebo-Only Group
Summary
This study is evaluating whether a parent-mediated intervention can improve outcomes for children with autism.
Who is the study for?
This trial is for children with Autism Spectrum Disorder (ASD) or social communication impairments who attend weekly sessions with a provider. Parents or guardians must be over 18, speak English or Spanish, and have not received Reciprocal Imitation Training (RIT) before. Children with visual, hearing, or motor conditions that affect RIT participation are excluded.
What is being tested?
The study aims to improve early intervention services for children with ASD by training providers in the Part C Early Intervention system to use an evidence-based parent-mediated approach called Reciprocal Imitation Training (RIT).
What are the potential side effects?
Since this trial involves educational and behavioral interventions rather than medical treatments, traditional side effects are not applicable. However, there may be varying responses to the training from both children and parents.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My child has been diagnosed with autism or has trouble communicating socially.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My child or I have had therapy or coaching in a developmental intervention before.
Select...
My child has conditions affecting sight, hearing, or movement that may limit participation in the therapy or assessments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to 9 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 9 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adapted Motor Imitation Scale (MIS)
Initiation of Joint Attention
Parenting Efficacy Scale (PES)
+4 moreSecondary study objectives
Family Life Impairment Scale (FLIS)
Language Environment Analysis (LENA) Vocal Complexity
Language Environment Analysis (LENA) Vocal Contingency
+2 moreOther study objectives
Developmental Play Assessment (DPA
Parenting Stress Index-Short Form
Vineland-3
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: RIT Training GroupExperimental Treatment1 Intervention
Providers in the RIT group (n=80) will receive intensive training (online tutorial, 2-day workshop, and virtual coaching and feedback in the field) in RIT and parent coaching and will be required to achieve fidelity prior to enrolling families from their caseload. They will then be asked to use the intervention with enrolled families for a minimum of 3 months. One intervention session per month for each enrolled family will be videotaped and scored for fidelity. Providers will receive monthly consultation from RIT trainers while these families are in the active treatment phase.
Group II: Treatment as UsualActive Control1 Intervention
Providers in the TAU group (n=80) will have three sessions videotaped and scored for each enrolled family to assess treatment differentiation. To incentivize agency participation, RIT training will be provided to the TAU group and other providers when data collection is complete.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Parent-mediated interventions for Autism Spectrum Disorder (ASD) involve training parents to implement evidence-based strategies to enhance their child's social communication and behavioral skills. These strategies include modeling appropriate behaviors, using reinforcement to encourage desired actions, and engaging in structured play activities.
The primary mechanism of action is the consistent and intensive support provided by parents in the child's natural environment, which can lead to more significant and sustained developmental improvements. This approach is particularly important for ASD patients as it utilizes the child's existing support system, making the intervention more accessible and potentially more effective over time.
Research-Based Intervention (RBI) for Autism Spectrum Disorder: Looking beyond Traditional Models and Outcome Measures for Clinical Trials.What are we targeting when we treat autism spectrum disorder? A systematic review of 406 clinical trials.Parent-mediated early intervention for young children with autism spectrum disorders (ASD).
Research-Based Intervention (RBI) for Autism Spectrum Disorder: Looking beyond Traditional Models and Outcome Measures for Clinical Trials.What are we targeting when we treat autism spectrum disorder? A systematic review of 406 clinical trials.Parent-mediated early intervention for young children with autism spectrum disorders (ASD).
Find a Location
Who is running the clinical trial?
University of WashingtonLead Sponsor
1,816 Previous Clinical Trials
1,913,908 Total Patients Enrolled
17 Trials studying Autism Spectrum Disorder
3,838 Patients Enrolled for Autism Spectrum Disorder
Michigan State UniversityOTHER
198 Previous Clinical Trials
684,800 Total Patients Enrolled
8 Trials studying Autism Spectrum Disorder
1,429 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,525 Total Patients Enrolled
84 Trials studying Autism Spectrum Disorder
40,812 Patients Enrolled for Autism Spectrum Disorder
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My parents are 18 years old or older.My parents can speak English or Spanish.My parents are 18 years old or older.My child or I have had therapy or coaching in a developmental intervention before.My child has conditions affecting sight, hearing, or movement that may limit participation in the therapy or assessments.My child has been diagnosed with autism or has trouble communicating socially.Parents are either the biological parents or custodial guardians of a child.
Research Study Groups:
This trial has the following groups:- Group 1: RIT Training Group
- Group 2: Treatment as Usual
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger